Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Feb 12 2024

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-12-2024-3

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 12, 2024, titled "Aurobindo Pharma receives USFDA Approval for Deflazacort Tablets, 6 mg, 18 mg, 30 mg, and 36 mg".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases